Grant: CIHR Clinician Scientist - Phase 1
McGill University
$172,500.00
Molecular characterization of UFM1 and exploration of its relationship with hereditary multiple system atrophy
FY 2009-10
Summary
Multiple system atrophy (MSA) is a severe neurodegenerative disorder similar to Parkinson's disease but complicated by failure of the autonomic nervous system and incoordination. Mutations in ubiquitin-fold modifier 1 (UFM1) were recently identified in a French-canadian form of cerebellar MSA. While the function of UFM1 is still unknown, its structure is very similar to that of ubiquitin, a molecule which associates with other proteins to influence their role or movement in cells and there is evidence suggesting that UFM1 acts in a similar manner. We suspect that mutations in UFM1 play an important role in the death of subsets of neurons seen in patients suffering from MSA, and because UFM1 is the very first gene associated with MSA anywhere in the world, we think that understanding its role will be an important step towards the discovery of mechanisms responsible for this devastating disease. In this project, we will study the cellular and molecular characteristics of UFM1 and explore how mutations affect its normal function. Our very first aim will be to generate reliable reagents to study the protein. With these tools, we hope to identify other proteins modified by UFM1 and to determine the role of these modifications on cellular function. To get a clearer sense of exactly how mutations act in a living organism, we will introduce them in the fruit fly and look for signs of the disease. This strategy has been useful in the past and we hope it will get us closer to a treatment for this degenerative disorder.
Department
Program
CIHR Clinician Scientist - Phase 1
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
197280
Name
Duquette Antoine
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Molecular characterization of UFM1 and exploration of its relationship with hereditary multiple system atrophy
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$172,500
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Drosophila; Genetics; Multiple System Atrophy; Neurodegeneration; Parkinsonism; Post-Translational Modification; Ubiquitination; Ufm1
Abstract
Multiple system atrophy (MSA) is a severe neurodegenerative disorder similar to Parkinson's disease but complicated by failure of the autonomic nervous system and incoordination. Mutations in ubiquitin-fold modifier 1 (UFM1) were recently identified in a French-canadian form of cerebellar MSA. While the function of UFM1 is still unknown, its structure is very similar to that of ubiquitin, a molecule which associates with other proteins to influence their role or movement in cells and there is evidence suggesting that UFM1 acts in a similar manner. We suspect that mutations in UFM1 play an important role in the death of subsets of neurons seen in patients suffering from MSA, and because UFM1 is the very first gene associated with MSA anywhere in the world, we think that understanding its role will be an important step towards the discovery of mechanisms responsible for this devastating disease. In this project, we will study the cellular and molecular characteristics of UFM1 and explore how mutations affect its normal function. Our very first aim will be to generate reliable reagents to study the protein. With these tools, we hope to identify other proteins modified by UFM1 and to determine the role of these modifications on cellular function. To get a clearer sense of exactly how mutations act in a living organism, we will introduce them in the fruit fly and look for signs of the disease. This strategy has been useful in the past and we hope it will get us closer to a treatment for this degenerative disorder.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Duquette, Antoine
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $172,500~ $0~